Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,309 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

NCT04281537

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Amicus Therapeutics, Inc. Philadelphia, Pennsylvania, United States
  • Instituto de Genética e Erros Inatos do Metabolismo (IGEIM) São Paulo, Brazil
  • Keio University Hospital Tokyo, Japan
  • Yokohama Municipal Citizen's Hospital Yokohama, Japan
View Trial Details
Completed

A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

NCT06431763

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Stuttgart, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Lichtenfels, Bavaria, Germany
  • Novartis Investigative Site Muehldorf Am Inn, Bavaria, Germany
View all 55 locations
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

NCT04659863

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia - Homozygous, +10 more
Locations
  • Excel Medical Clinical Trials LLC Boca Raton, Florida, United States
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Bron, France
  • University General Hospital of Ioannina Ioannina, GR, Greece
View Trial Details
Completed

A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

NCT06555640

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Baoding No.1 Central Hospital Baoding, China
  • The First Affiliated Hospital of Baotou Medical College Baotou, China
  • Peking University First Hospital Beijing, China
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, China
View all 35 locations
View Trial Details
Completed

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

NCT05888103

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +12 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Zhongshan, Guangdong, China
View all 28 locations
View Trial Details

Related conditions